Disseminated intravascular coagulation after inhibition of fibrinolysis with tranexamic acid (AMCA) and proteinase inhibitor Trasylol in experimental traumatic and haemorrhagic shock.
D000818:Animals; D007611:Aprotinin / Q000494:pharmacology*; D001769:Blood; D001792:Blood Platelets / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D003509:Cyclohexanecarboxylic Acids / Q000494:pharmacology*; D003864:Depression, Chemical; D004211:Disseminated Intravascular Coagulation / Q000097:blood* / Q000378:metabolism; D005165:Factor V / Q000378:metabolism; D005169:Factor VIII / Q000378:metabolism; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D005342:Fibrinolysis / Q000187:drug effects*; D006400:Hematocrit; D006454:Hemoglobins / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D007457:Iodine Radioisotopes; D008297:Male; D010973:Platelet Adhesiveness / Q000187:drug effects; D011817:Rabbits; D012771:Shock, Hemorrhagic / Q000097:blood*; D012774:Shock, Traumatic / Q000097:blood*; D013268:Stimulation, Chemical; D013997:Time Factors
D003509:Cyclohexanecarboxylic Acids; D006454:Hemoglobins; D007457:Iodine Radioisotopes; D005165:Factor V; D005169:Factor VIII; D005340:Fibrinogen; D007611:Aprotinin